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Dynamin-related protein 1 is required for normal
mitochondrial bioenergetic and synaptic function in
CA1 hippocampal neurons
LY Shields1,2,7, H Kim1,7, L Zhu1,3, D Haddad1, A Berthet1, D Pathak1, M Lam1,4, R Ponnusamy1, LG Diaz-Ramirez5, TM Gill1, H Sesaki6,
L Mucke1,2,3 and K Nakamura*,1,2,3
Disrupting particular mitochondrial fission and fusion proteins leads to the death of specific neuronal populations; however, the
normal functions of mitochondrial fission in neurons are poorly understood, especially in vivo, which limits the understanding of
mitochondrial changes in disease. Altered activity of the central mitochondrial fission protein dynamin-related protein 1 (Drp1)
may contribute to the pathophysiology of several neurologic diseases. To study Drp1 in a neuronal population affected by
Alzheimer’s disease (AD), stroke, and seizure disorders, we postnatally deleted Drp1 from CA1 and other forebrain neurons in mice
(CamKII-Cre, Drp1lox/lox (Drp1cKO)). Although most CA1 neurons survived for more than 1 year, their synaptic transmission was
impaired, and Drp1cKO mice had impaired memory. In Drp1cKO cell bodies, we observed marked mitochondrial swelling but no
change in the number of mitochondria in individual synaptic terminals. Using ATP FRET sensors, we found that cultured neurons
lacking Drp1 (Drp1KO) could not maintain normal levels of mitochondrial-derived ATP when energy consumption was increased by
neural activity. These deficits occurred specifically at the nerve terminal, but not the cell body, and were sufficient to impair
synaptic vesicle cycling. Although Drp1KO increased the distance between axonal mitochondria, mitochondrial-derived ATP still
decreased similarly in Drp1KO boutons with and without mitochondria. This indicates that mitochondrial-derived ATP is rapidly
dispersed in Drp1KO axons, and that the deficits in axonal bioenergetics and function are not caused by regional energy gradients.
Instead, loss of Drp1 compromises the intrinsic bioenergetic function of axonal mitochondria, thus revealing a mechanism by
which disrupting mitochondrial dynamics can cause dysfunction of axons.
Cell Death and Disease (2015) 6, e1725; doi:10.1038/cddis.2015.94; published online 16 April 2015
Mitochondrial dynamics – the balance between mitochondrial
fission and fusion – regulates mitochondrial quality control by
segregating poorly functioning mitochondria for degradation
while mixing the contents of healthy mitochondria.1,2 In
neurons, fission uniquely facilitatesmovement of mitochondria
down narrow distal axons.3,4 Disruptions of this movement,
and of other neuron-specific functions, may explain why
systemic mutations in mitochondrial fusion and fission
proteins specifically cause death of neurons. However, the
roles and requirements of these proteins also differ between
neuronal types.1 For example, mutations in the fusion protein
optic atrophy 1 cause degeneration of retinal ganglion
neurons,5 and mutations in the fusion protein mitofusin-2 or
the fission protein ganglioside-induced differentiation-asso-
ciated protein 1 cause peripheral neuropathy (Charcot-Marie-
Tooth types 2A and 4A6,7).
There are several potential reasons why specific neurons
have unique requirements for fission–fusion proteins. First, the
functions of these proteins may be more critical in vulnerable
neuronal populations. Recently, we showed that most mid-
brain DA neurons are uniquely vulnerable to loss of the central
mitochondrial fission protein dynamin-related protein 1
(Drp1),4 a GTPase recruited to fission sites on the outer
mitochondrial membrane.1 Loss of Drp1 depletes axonal
mitochondria, which is followed by axonal degeneration and
neuronal death. However, a subpopulation of midbrain DA
neurons survive, despite losing their axonal mitochondria,
suggesting that they have lower needs for energy or other
mitochondrial functions in their axons.4 Do unique require-
ments for mitochondrial dynamics underlie differential neuro-
nal vulnerability? Do resistant neurons compensate with other
fission or fusion mechanisms? Do the functions of fission differ
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between neurons? Notably, Drp1 may also have mitochon-
dria-independent functions in synaptic vesicle release.8
Addressing these issues could help elucidate the physiologi-
cal functions of mitochondrial dynamics in the nervous system
and reveal how shifts in the fission–fusion balance contribute
to selective neuronal death in neurodegenerative diseases,
including Huntington’s disease, Parkinson’s disease and
Alzheimer’s disease (AD),1,4 and in other neurologic dis-
orders, including stroke and epilepsy.9–11
To understand mitochondrial dynamics, it would be useful to
know why mitochondrial fission is needed in the nervous
system in the first place, and how loss of fission affects
mitochondrial functions in specific cell types. Notably, Drp1
knockout did not change respiration or ATP levels in
resuspended mouse embryonic fibroblasts (MEFs),12,13 indi-
cating that mitochondrial fission is not required for respiration
in these cells. However, neuronal respiration may be more
sensitive to Drp1 loss. Indeed, Drp1 loss markedly decreased
the number of mitochondria in axons and the cell body in
midbrain DA neurons in vivo,4 and reduced staining of
complex I and IV activity in cerebellar neurons in vivo.14
However, it is unclear whether these changes translate into
decreased ATP levels in neurons and, if so, whether this
decrease compromises neuronal function. Furthermore,
Drp1 loss caused cell death in cerebellar and most midbrain
DA neurons,4,14 which challenges our ability to dissociate
the specific effects of Drp1 loss on mitochondrial
function from other non-specific changes that accompany
cell death.
To learn how disrupting mitochondrial fission contributes to
selective neurodegeneration, we studied the function of Drp1
in CA1 hippocampal neurons and its role in mitochondrial
bioenergetics. Surprisingly, despite losing Drp1, most CA1
neurons survived for more than 1 year in vivo, although their
function was compromised, leading to deficits in synaptic
transmission and memory. To begin to understand how loss of
Drp1 causes neuronal dysfunction, we examined the role of
Drp1 in mitochondrial bioenergetics. We found that Drp1 is
required to maintain normal mitochondrial-derived ATP levels
specifically in axons (but not the cell body), and that the loss of
this function is unrelated to the distribution of mitochondria
within axons.
Results
To selectively delete Drp1 fromCA1 hippocampal neurons, we
bred floxed Drp1 mice13 with CamKIIalpha (CamKCre) mice,
which express Cre recombinase from P19 in a subset of
hippocampal neurons, including nearly all CA1 neurons, and
in scattered cortical and other neurons throughout the
forebrain.15,16 Drp1cKO (Drp1lox/lox; CamKII-Cre) mice were
the progeny of Drp1lox/lox and Drp1wt/lox; CamKII-Cre. Drp1WT
included control mice (Drp1wt/lox and Drp1lox/lox) lacking the
Cre transgene. Drp1cKO mice were born in roughly normal
Mendelian proportions (control 46.6%, Drp1 heterozygotes
29.8%, Drp1cKO 23.6%, n=191), and no differences in
survival were noted. Drp1cKO and control mice had similar
body weights through 10 months of age (Supplementary
Figure S1a).
To confirm Cre expression in CA1 neurons, we crossed
Drp1cKO mice with floxed tdTomato reporter mice.17 In 1-
month-old tdTomato-CamKCre control (tdTomatolox/wt; Cam-
KII-Cre) and Drp1cKO-tdTomato-CamKCre (Drp1lox/lox; tdTo-
matolox/wt; CamKII-Cre) mice, ≥ 98% of CA1 neurons
(immunostained for NeuN) showed tdTomato fluorescence,
indicating that they expressed Cre (Supplementary Figure
S1b). Conversely, all TdTomato+ cells expressed NeuN,
indicating that Cre was only expressed in neurons
(Supplementary Figure S1c). We found that Cre was
expressed in ~ 50% of cells in the dentate gyrus, though
at much lower levels than in CA1 (Supplementary Figure
S1d and e). There was very little expression of Cre in CA3
neurons, but it was also expressed in scattered neurons
throughout the cortex (not shown). CA1 neurons in Drp1cKO
mice had markedly decreased Drp1 expression at 1 year of
age (Supplementary Figure S1f and g).
Drp1 loss decreases CA1 volume but has little effect on
the survival of CA1 neurons. Deleting Drp1 promotes loss
of most midbrain DA neurons within 1–2 months,4 and most
cerebellar Purkinje neurons within 6 months.14 To determine
whether Drp1cKO similarly compromises survival of CA1
neurons, we examined the effects of Drp1cKO on CA1
volume (Figures 1a, b and d). Surprisingly, at 5 months,
CA1 volume did not significantly decrease, and by 1 year,
CA1 volume was still ~ 70% of controls (Figure 1d). There
was a similar trend toward decreased volume of the entire
hippocampus at 13 months (P= 0.06) (Figures 1c and e),
suggestive of hippocampal atrophy in Drp1cKO mice.
The density of NeuN-positive cells within CA1 was not
significantly changed even at 1 year (Figure 1f). Consider-
ing the decrease in CA1 volume at 1 year, loss of Drp1 may
have caused synaptodendritic rarefaction,18,19 in addition to
some neuronal death. Nonetheless, most CA1 neurons in
Drp1cKO mice survive beyond 1 year, indicating that CA1
hippocampal neurons are more resistant to Drp1 loss than
cerebellar Purkinje neurons and most midbrain DA
neurons.4,14
Drp1 is required for normal spatial memory and synaptic
function. To determine whether Drp1 is required for normal
hippocampal function, we examined how Drp1cKO affects
spatial learning and memory in the Morris water maze.
Drp1cKO mice showed normal learning at 5 and 8 months,
based on an analysis of learning curves with a linear mixed
effects model20 (Figure 2a and Supplementary Figure S2).
However, in probe trials carried out 24 and 72 h after the last
training trial, these mice did not favor the target quadrant as
well as controls (Figure 2b). Drp1cKO mice performed
normally in cued platform trials, had normal swim speeds,
and showed no abnormalities in open-field behavior
(Figure 2a and Supplementary Figure S3a and b), indicating
that their water maze deficits were not caused by deficits in
vision or motor function.
Next, we examined the function of CA1 neurons in acute
hippocampal slices with extracellular field recordings in CA1
after stimulating the Schaffer collaterals. Drp1cKO mice had
markedly lower field excitatory post-synaptic potentials
(EPSPs) than controls (Figure 2c). To determine whether
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these effects result from pre- or post-synaptic changes, we
examined paired-pulse ratios, which were unchanged in
Drp1cKO slices (Figure 2d). These results suggest that pre-
synaptic strength was normal in Drp1cKO mice, consistent
with the lack of Cre expression in most CA3 neurons
(Supplementary Figure S1d and e). Therefore, deficits in
synaptic transmission likely resulted from post-synaptic
changes in CA1 pyramidal cells.
Drp1 loss changes morphology, but not mass or synaptic
localization, of mitochondria in CA1 neurons. To under-
stand how Drp1 loss compromises neuronal function, we first
examined its effect on mitochondrial morphology and
distribution in CA1 neurons. At the cell body, many Drp1cKO
neurons developed characteristic swollen mitochondria
between 1 and 3 months of age, identified by Tom20
immunofluorescence (Figures 3a and b), similar to those
observed after Drp1 deletion in other neuronal types.4,13 This
suggests that mitochondrial fission is lost between 1 and
3 months. Surprisingly, the percentage of neurons with
swollen mitochondria decreased somewhat between 5 and
12 months (Figure 3b), despite having low levels of Drp1
(Supplementary Figure S1f and g). However, unlike the
effects of Drp1 loss in DA neurons,4 mitochondrial content
(mitochondrial intensity/cytoplasmic area) was unchanged in
CA1 neurons, even in 1-year-old animals (Figure 3c).
Mitochondrial content was also unchanged in proximal
dendrites (Figures 3d and e), and the morphology of dendritic
mitochondria was grossly normal despite swollen mitochon-
dria at the cell body. Drp1cKO mitochondria were larger, but
their length/width (Feret) ratio was unchanged (Figures 3f–h).
Although the cristae structure was intact in most Drp1cKO
mitochondria, some larger mitochondria had disrupted cristae
(Figure 3f).
Next, we examined the mitochondria in CA1 axons,
particularly those that project to the entorhinal cortex.21
We visualized the synapses and mitochondria (Figure 3i)
by co-injecting Cre-dependent reporter viruses expressing
Figure 1 Drp1cKO mice develop atrophy of CA1. (a and b) NeuN staining of (a) 5- and (b) 12-month-old Drp1WT (control) and Drp1cKO brain sections, with CA1 defined by
calbindin staining (not shown). The lateral margin of CA1 is demarcated by hashed white lines. Scale bars are 400 μm. (c) Sections from 13-month-old tdTomato-Drp1cKO
(Drp1lox/lox; tdTomatolox/wt; CamKII-Cre) and tdTomato-CamKCre control (Drp1wt/wt; tdTomatolox/wt; CamKII-Cre) stained with peroxidase for dsRed to visualize tdTomato+ cells.
Scale bar is 400 μm. (d) CA1 volume of Drp1cKO mice was similar to controls at 5 months, but significantly decreased by 12 months. Data are means± S.E.M., ns= not
significant, *Po0.05 versus respective control group by two-way ANOVA and Sidak post hoc test, n= 3 mice/group (with 10–18 slices of hippocampus examined per mouse).
(e) 13-month-old tdTomato-Drp1cKO mice showed a strong trend toward decreased total hippocampal volume versus controls. Data are means± S.E.M.; P= 0.06 by unpaired
two-tailed t-test, n= 3–4 mice/group (with 12–26 slices of hippocampus examined per mouse). (f) Drp1cKO showed no change in average CA1 cell density at 5 or 12 months
compared with controls. Data are means± S.E.M.; ns by two-way ANOVA, n= 3–4 mice/group (four slices examined per mouse)
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Figure 2 Drp1 loss produces deficits in memory and synaptic transmission. (a) Learning was evaluated by Morris water maze (MWM) hidden-platform training results
(sessions 1–10). Drp1cKO mice did not show significant learning deficits at 5 or 8 months (analyzed with a linear mixed effects model and Holm post hoc test). Visible platform
training results (days v1–v3) did not differ between Drp1WT (control) and Drp1cKO. (b) Memory was evaluated during MWM probe trials at 24 and 72 h, based on the percent time
spent in the target quadrant compared with the average of the other three quadrants. Drp1cKO mice showed memory deficits at both 5 and 8 months. Data are means±S.E.M.;
ns= not significant, *Po0.05, **Po0.01, ***Po0.001 by paired one-tailed t-test, n= 7–16 mice/group. (c and d) The impact of Drp1cKO on the electrophysiologic function
of CA1 neurons was assessed in acute hippocampal slices by stimulating the Schaffer collaterals, and performing extracellular field recordings in CA1. At 7–9 months,
Drp1cKO mice showed impaired synaptic transmission in CA3-CA1 (input/output slopes), but no change in paired-pulse facilitation compared with Drp1WT (control). Data are
means± S.E.M.; *Po0.05, **Po0.01, ****Po0.0001 by two-way ANOVA with repeated-measures and Sidak post hoc test, n= 13–17 slices/group
Figure 3 Drp1 loss alters mitochondrial morphology but fails to deplete mitochondria from CA1 synapses. (a and d) Staining for the mitochondrial marker Tom20 in the CA1 of
brain slices from 5-month-old (a) and 1-year-old (d) Drp1cKO and Drp1WT (control) mice. Outlines of cell bodies and dendrites (indicated by the stippled outlines and
arrowheads) and the nucleus (inner stippled circles) were defined by MAP2 immunostaining (not shown). (b) CA1 cells showed an increase in the number of swollen mitochondria
between 1 and 3 months, though the numbers decreased somewhat by 12 months. Data are means± S.E.M.; *Po0.05, ***Po0.001, ****Po0.0001 versus the control group by
two-way ANOVA, n= 3 mice/group (with 18–76 cells/mouse). (c) However, CA1 cells did not show any change in mean Tom20 fluorescence over the cytoplasm (cell body,
excluding the nucleus) at 5 months or 1 year (e), nor in the dendrites at 1 year. Data are means± S.E.M.; not significant by two-way ANOVA (cell body) and unpaired two-tailed
t-test (dendrites), n= 3 mice/group (with 3–5 slices/mouse). (f and g) Ultrastructural analysis of CA1 neurons at the cell body revealed larger mitochondria in Drp1cKO mice than
Drp1WT (control). Dots on the scatter graph show the areas of individual mitochondria. (h) Mitochondria in Drp1cKO and controls were equally round, as measured by ratio of
feret diameter over minimum feret diameter. Red bars show mean± S.D.; ns= not significant, ****Po0.0001 versus the control group by unpaired two-tailed t-test, n= 67–223
mitochondria/group. (i) AAVs expressing mitochondria-targeted GFP (mitoGFP; green, to visualize mitochondria) and mCherry-synaptophysin (red, to visualize synaptic boutons)
in DIO constructs59 that express only in Cre-expressing neurons4 were co-injected into the CA1 of Drp1cKO (Drp1lox/lox; CamKII-Cre) and CamKCre (CamKII-Cre) control
mice, and examined at 7 months. (j) The size of axonal mitochondria was unchanged by Drp1cKO (k), but bouton size showed a trend toward increased size (P= 0.055).
(l) The percentage of synaptic boutons containing mitochondria was unchanged. Data are means± S.E.M.; ns= not significant versus control group by unpaired two-tailed t-test,
n= 3–4 mice/group (total of 86–1279 mitochondria). Scale bars are 5 μm (a, d and i) and 1 μm (f)
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mCherry-synaptophysin and mitoGFP4 into CA1 of 6-month-
old Drp1cKO (Drp1lox/lox; CamKII-Cre) and CamKCre
(CamKII-Cre) control mice. Animals were killed at ~ 7 months,
and we confirmed that all injections hit CA1, but not areas
outside of the hippocampus (not shown). Mitochondria in
Drp1cKO axons were not larger than controls (Figure 3j).
Drp1 in mitochondrial bioenergetics at the synapse
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There was a strong trend for increased size of boutons
(Figure 3k). Interestingly, unlike midbrain DA axons,4 the
percentage of boutons containing mitochondria was
unchanged (Figure 3l), suggesting that mitochondria in
CA1 axons target the synapse independent of Drp1.
Drp1 loss compromises mitochondrial energy produc-
tion in axons. In Drp1cKO mice, the synaptic deficits and
disrupted mitochondrial morphology suggest that mitochon-
dria lacking Drp1 may have impaired bioenergetic function.
To examine the effects of Drp1 loss on energy levels, we
tested the effect of Drp1 deletion (Drp1KO) on respiration
and glycolysis in immortalized MEFs with a Seahorse
Extracellular Flux (XF) Analyzer (Supplementary Figure 4).
By comparing Drp1KO and control lines, we found that
respiration (basal and maximal, after treatment with the
uncoupler FCCP) and glycolysis (basal and after treatment
with the ATP synthase inhibitor oligomycin) were unaffected
by Drp1 loss (Supplementary Figure S4a and S4b). These
findings are consistent with prior studies in which cell lines
failed to reveal deficits in the mitochondrial membrane
potential or respiration of Drp1KO mitochondria,12,13 and
indicate that Drp1 is not required for normal respiratory
function in cell lines.
Neurons, however, are preferentially vulnerable to deficits in
mitochondrial dynamics.5–7,22 Drp1KO neurons have lower
mitochondrial membrane potential at the cell body in culture,4
and cerebellar neurons lacking Drp1 show reduced staining of
complex I and IV activity before degeneration in vivo.14 These
results suggest neurons selectively require mitochondrial
fission for energy production. To determine whether Drp1 is
required for normal mitochondrial bioenergetic function in
neurons, we examined the effects of Drp1 loss on ATP levels in
postnatal hippocampal cultures from floxed Drp1 mice.13 We
examined how Drp1 loss affects the distribution of mitochon-
dria in axons by co-transfecting cells with either mCherry-Cre
(to delete Drp1) or mCherry control, mitoGFP (to visualize
mitochondria), and BFP2-synaptophysin (to distinguish axons
from dendrites). Loss of Drp1 markedly increased the size of
mitochondria within axons (Figures 4a and b) and the distance
between mitochondria (Figure 4c). These findings are similar
to those in studies that knocked down Drp1 with RNAi.23 The
percentage of synaptic boutons containing mitochondria was
unchanged (Figure 4d), consistent with our in vivo results
(Figure 3l).
To assess how loss of mitochondrial fission affects intrinsic
bioenergetic function in neurons, we co-transfected Drp1lox/lox
hippocampal neurons with Cre recombinase (to delete
Drp1) or a vector control, the ATP-based FRET sensor
(ATP1.03YEMK),24 and mitoFarRed (to visualize mitochondria).
We examined ATP levels when neurons were in Tyrodes buffer
with standard high glucose (~30mM, greater than extracel-
lular brain glucose levels, which are ~ 1–1.5mM 25,26) and
10mM pyruvate (where glycolysis or respiration supports ATP
Figure 4 Drp1KO disrupts the distribution of mitochondria at the nerve terminal in cultured neurons. Primary hippocampal cultures from floxed Drp1 mice were co-transfected
with either mCherry-Cre (to delete Drp1 (Drp1KO)) or mCherry (control), mitochondria-targeted GFP (to visualize mitochondria), and BFP2-synaptophysin (to distinguish axons
from dendrites). (a) Drp1KO and control synapses with (arrowhead) and without (arrow) mitochondria. (b) Drp1KO axons had significantly bigger mitochondria. Data are
means± S.E.M.; *Po0.05 and ****Po0.0001 versus respective controls by two-way ANOVA with repeated-measures and Sidak post hoc test, n= 4–5 coverslips/group. (c)
Drp1KO also markedly increased the distance between axonal mitochondria. **Po0.01, versus control by unpaired two-tailed t-test, n= 3 coverslips/group. (d) The proportion of
boutons occupied by mitochondria was unchanged. ns by two-way ANOVA, n= 4–5 coverslips/group. Scale bar is 10 μm
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production27). As expected, Drp1KO failed to change baseline
ATP levels at the cell body or synapse (Figure 5a).
Next, we determined whether Drp1KO mitochondria have
normal bioenergetic function. We examined ATP levels in the
acute absence of glucose and with glycolytic inhibitors (2.5–
5mM2-deoxyoglucose, 1 mM iodoacetate) to force neurons to
rely on mitochondrial ATP. Under these conditions, Drp1KO
axons could not maintain their ATP levels after acute electrical
stimulation (10 Hz for 60 s), which augments ATP require-
ments in axons by increasing synaptic vesicle cycling,27
(Figure 5b). Therefore, Drp1KO mitochondria cannot maintain
ATP levels in axons when energy requirements are increased.
In contrast, Drp1KOmitochondriamaintained ATP levels at the
cell body (Figure 5c), suggesting axonal mitochondria have
less capacity to maintain ATP levels than those at the cell body
and/or that neural activity selectively increases ATP consump-
tion in axons.
Why does Drp1KO decrease mitochondria-derived ATP in
axons? Perhaps Drp1KO mitochondria have intrinsic deficits
in their ability to produce ATP. Alternatively, axonal mitochon-
dria are farther apart in Drp1KO neurons (Figure 4c), which
may create regional gradients of ATP between them. To
distinguish these possibilities, we examined ATP levels in
synapses, with and without mitochondria (Figures 5d and e).
Surprisingly, despite increased separation between
mitochondria in Drp1KO axons, ATP levels were similar in
boutons with and without mitochondria. These results suggest
that Drp1KO axonal mitochondria have intrinsic deficits in their
ability to produce ATP.
To determine whether decreased ATP in Drp1KO synapses
is significant, we examined its impact on synaptic vesicle
cycling, a key function that consumesmuchATP in axons.27 To
observe synaptic vesicle cycling in individual boutons, we
used a VGLUT1-pHluorin reporter with a pH-sensitive GFP
targeted to the lumen of synaptic vesicles.28 In the acidified
lumen of the vesicle, pHluorin does not fluoresce; however,
after fusing with the plasma membrane at the synapse and
becoming exposed to the alkaline environment, pHluorin
fluoresces and is re-quenched with re-internalization and re-
acidification of the vesicle.28Without glycolysis, mitochondrial-
derived ATP is required to support pre-synaptic ATP levels and
maintain endocytosis.27 However, deleting Drp1, while simul-
taneously inhibiting glycolysis, completely blocked endocyto-
sis after 10 Hz ×60 s stimulation (Figure 5f), which promotes
the preferential release of vesicles in the recycling pool.29
Therefore, mitochondria require Drp1 for normal ATP produc-
tion in axons, and its loss decreases mitochondria-derived
ATP sufficiently to impair synaptic vesicle cycling. These
bioenergetic defects may underlie the electrophysiologic and
functional deficits in Drp1cKO mice in vivo.
Figure 5 Drp1 is required for normal mitochondrial bioenergetics, specifically in axons. Drp1-floxed primary hippocampal cultures were co-transfected with an ATP-based
FRET sensor (ATP1.03YEMK),24 mitoFarRed (to visualize mitochondria), and either a control vector (con) or Cre (Drp1KO). (a) At baseline, Drp1KO and control neurons in
pyruvate and glucose showed similar levels of ATP in boutons and at the cell body, as measured by FRET. (b) In the acute absence of glucose, Drp1KO neurons showed
significantly decreased ATP levels at the synapse after stimulation at 10 Hz*60 s (blue horizontal bars) when forced to fully rely on mitochondria for ATP (by blocking glycolysis with
glycolytic inhibitors 2-deoxyglucose (2-DG) and iodoacetate (IAA) (orange horizontal bar)). (c) ATP levels were not depleted at the cell body, even when glycolysis was inhibited. (d
and e) ATP levels were not changed in synaptic boutons, with and without mitochondria, at baseline or after stimulation. Data are means±S.E.M.; *Po0.05, ***Po0.001 versus
control by two-way ANOVA with repeated-measures and Sidak post hoc test, n= 10 coverslips/group, (with 80–140 boutons and 10–15 cell bodies sampled per group)). (f)
VGLUT1-pHluorin was used to measure synaptic vesicle cycling in individual synapses. Drp1KO markedly impaired endocytosis when glycolysis was blocked. Data are
means±S.E.M.; ***Po0.001 versus control group by unpaired two-tailed t-test for extent of endocytosis ((amplitude endocytosis)/(amplitude exocytosis)). n= 8–10 coverslips/
group, (86–111 boutons per group)
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Discussion
Disrupted mitochondrial dynamics may contribute to the
pathophysiology of neurologic disorders that affect several
distinct neuronal populations.1,9–11 However, little is known
about why changes in the fission–fusion balance affect
neurons more than other cells, or why some neuronal
populations are more susceptible than others. Here, we
showed that CA1 hippocampal neurons are more resistant
to Drp1 loss than previously studied neuronal types, although
they still require Drp1 for normal synaptic function.We showed
that Drp1 loss in hippocampal neurons compromises the
intrinsic function of axonal mitochondria, causing significant
deficits in their ability to maintain normal ATP levels and
synaptic vesicle cycling.
Mitochondrial fission is required for the bioenergetic
function of axonal mitochondria. Why are neurons vulner-
able to disruptions in mitochondrial fusion and fission
proteins?5–7,22 Mitochondrial fission facilitates targeting of
mitochondria down long distal processes, and loss of this
targeting likely contributes to neuronal vulnerability.3,4 How-
ever, impaired axonal targeting cannot explain deficits in CA1
hippocampal neurons; these cells maintain mitochondria in
axons, even without Drp1. Instead, we showed that Drp1 is
required for intrinsic respiration of mitochondria in axons, as
Drp1KO mitochondria cannot maintain normal ATP levels in
their axons when under increased-energy demands.
Several reasons may explain why mitochondrial fission is
required specifically for axonal bioenergetics. First, disrupted
fission may compromise the intrinsic function of axonal
mitochondria, possibly by changing their normal turnover,30
which could cause dysfunctional mitochondria to accumulate.
Indeed, the rate of mitochondrial turnover may differ greatly
between mitochondria in axons and the cell body.31 Second,
axonal bioenergetics may be particularly sensitive to changes
in mitochondrial distribution. Drp1KO markedly increased the
space between axonal mitochondria in culture, which might
cause regional energy gradients that would not occur at the
cell body. However, we found that mitochondria-derived ATP
levels were similar in Drp1KO boutons with and without
mitochondria, despite the increased distance between mito-
chondria.Whether the distance betweenmitochondria may be
even greater in vivo to potentially create these gradients is
unknown. Nonetheless, these data suggest that changes in
the distribution of axonal mitochondria alone cannot explain
the susceptibility of axons to Drp1 loss.
Third, Drp1KO compromises the intrinsic function of
mitochondria in the cell body and axons, but the energy
demands are greater in axons. Indeed, synaptic transmission
is the primary consumer of energy in the brain,32 and in
particular, synaptic vesicle cycling appears to require large
amounts of energy.27 The disproportionate energy needs in
axons may contribute to their early loss in neurodegenerative
diseases involving energy failure and in mitochondrial models
of these diseases.4,33–36 In addition, the energy requirement in
axons may vary considerably between neuronal types. For
instance, SN DA neurons have particularly long projections,
large axonal arbors, and poor myelination,37,38 which might
require more energy than other neuronal populations.
CA1 hippocampal neurons are relatively resistant to Drp1
loss. Better understanding why different neuronal popula-
tions have unique requirements for specific mitochondrial
fission and fusion proteins could shed light on the normal
functions of mitochondrial dynamics in the brain and on
how disruptions of these functions contribute to neuro-
degeneration.1 For example, cerebellar Purkinje cells die
within 6 months of losing Drp1,14 but most midbrain DA
neurons die within 1 month.4 However, a subset of midbrain
DA neurons and their axons are far more resistant to Drp1
loss and survive with very few axonal mitochondria.4 Here,
we showed that CA1 hippocampal neurons are also resistant
to Drp1 loss, with most surviving to at least 1 year. However,
in contrast to resistant midbrain DA neurons,4 Drp1 loss fails
to decrease the number of mitochondria in CA1 axon
terminals. Although some CA1 terminals might have actually
lost mitochondria but atrophied before examination at
7 months, mitochondria within the surviving CA1 terminals
sharply contrast with our observations in Drp1KO midbrain
dopaminergic terminals, where surviving axons lose almost
all of their mitochondria.4
Why Drp1 loss differentially affects axonal mitochondria in
these two neuron types is unknown. Hippocampal neurons
might have distinct pathways for mitochondrial fission that are
not present in midbrain DA neurons. However, this seems
unlikely: deleting Drp1 impacts mitochondrial morphology at
the cell body similarly in both cell types. Alternatively,
mitochondria may be preferentially lost from midbrain DA
axons because they are longer and more susceptible to
differences in axonal motility. However, axonal length alone
cannot explain the differences, as even the proximal axons
of nigrostriatal DA neurons lacking Drp1 have fewer
mitochondria.4 Other steric or undefined differences in
mitochondria and/or axons may contribute to differences in
axonal targeting. We believe mitochondria in CA1 axons
reflect the continued ability of mitochondria to reach the axon
after Drp1 is lost, rather than an inability to degrade those
mitochondria that reached the nerve terminal before Drp1 was
lost. Indeed, we examined the synaptic mitochondria
44 months after appearance of the characteristic swollen
mitochondria with Drp1 loss at the cell body, a time interval that
far exceeds estimates of mitochondrial lifespan.39 None-
theless, we cannot exclude this possibility, as very little is
known about mitochondrial lifespan in neurons and their
axons, and Drp1KO could prolong their lifespan by impairing
mitochondrial turnover.40
Implications for Drp1 in the pathophysiology of neurolo-
gic diseases. We showed that CA1 hippocampal neurons –
susceptible to degeneration in AD, stroke, and seizure
disorders41–43 – require Drp1 for respiration and synaptic
function. Interestingly, Drp1 has been mechanistically
linked to the pathogenesis of AD in several studies. For
example, amyloid-beta may mediate toxicity by increasing
Drp1 function and producing excessive fission.44 In contrast,
mutant tau produces toxicity by downregulating Drp1 in
Drosophila.45 With the current study, these findings
suggest that too much and too little fission are detrimental
and that normal neuronal functions may depend on a fine
balance between mitochondrial fission and fusion. Changes
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in mitochondrial fission may also affect the pathophysiology
of stroke and seizure, in which Drp1 is a therapeutic
target.9–11 Furthermore, AD, seizures, and stroke are
associated with increased synaptic transmission and impaired
metabolism,31,46–48 and changes in mitochondrial fission
might contribute to or synergize with these alterations.
Our Drp1cKO mouse provides an excellent model to study
the effects of mitochondrial fission in these neurological
disorders. This model is the first to both avoid early
developmental changes and separate the normal functions
of Drp1 from cell death processes, which could confound
analyses. Building upon the physiological functions of Drp1
identified here, the Drp1cKO model can now be used to
elucidate the role of this protein in models of neurological
disorders that target the hippocampus.
Materials and Methods
Animals. Floxed Drp1 mice have been described.13 CamKCre15 and tdTomato
mice17 were obtained from Jackson Laboratory. Mice were group-housed in a
colony maintained with a standard 12 h light/dark cycle and given food and water ad
libitum. Experiments were performed on age-matched mice of either sex. No
differences between sexes were noted in any of the experiments. Experiments were
conducted according to the Guide for the Care and Use of Laboratory Animals, as
adopted by the National Institutes of Health, and with approval of the University of
California, San Francisco, Institutional Animal Care and Use Committee.
Behavioral testing. Learning and memory was assessed with the Morris
water maze (MWM) test.49 In brief, mice underwent two sessions of hidden-platform
training separated by a 2 h intersession rest. Each session consisted of two trials.
This training was performed each day for 5 days. The platform was removed and
memory probe trials were performed 24 and 72 h after the last training day. Three
sessions of visible platform training were performed the next day after training and
probe trials were complete, as a control.
EthoVision video-tracking system (Noldus, Wageningen, the Netherlands) was
used to record and track mice. Open field locomotor activity was performed as
described.4 In brief, mice were habituated for at least 1 h before recording activity for
15 min with an automated Flex-Field/Open Field Photobeam Activity System (San
Diego Instruments, San Diego, CA, USA). All behavioral experiments were performed
with the examiner blind to genotype.
Slice preparation and electrophysiology. Transverse hippocampal
slices were cut at 400 μm as described.50 In brief, mice were anesthetized by
isoflurane inhalation and killed by decapitation. Their brains were isolated and
immediately placed in an ice-cold solution containing 234 mM sucrose, 2.5 mM KCl,
1.25 mM NaH2PO4, 10 mM MgSO4, 26 mM NaCO3, 11 mM glucose, and 1.3 mM
ascorbic acid. Brains were sliced on a Leica VS100 vibroslicer (Leica, Nussloch,
Germany). Slices were incubated for at least 1 h in oxygenated artificial
cerebrospinal fluid (aCSF) containing 126 mM NaCl, 2.5 mM KCl, 1.25 mM
NaH2PO4, 1 mM MgSO4, 26 mM NaCO3, 10 mM glucose, and 2 mM CaCl2 at room
temperature (RT) before being transferred to a submerged recording chamber. Each
slice was equilibrated for 10–20 min before recording. For extracellular field EPSP
recordings, aCSF-filled glass pipette was placed in the stratum radiatum, and the
Schaffer-collateral pathway was stimulated with a concentric bipolar electrode.
Electrophysiological recordings were filtered, digitized, and acquired with WinLTP
(Bristol, UK, RRID:nif-0000-31907). Analysis was performed with WinLTP and
Original pro 8.0 (Origin Labs, Northampton, MA, USA).
Stereotaxic injection of recombinant adeno-associated virus
(AAV). Intracranial injections of AAV1-EF1α-DIO-mitoGFP (8 × 1012 VG/ml) or
mCherry-synaptophysin (3 × 1012 VG/ml)4 were performed in ~ 6-month-old
CamKCre or Drp1cKO mice. Mice were anaesthetized with 2,2,2-tribromoethanol
(Alfa Aesar, Ward Hill, MA, USA; 500 mg/kg) and secured with a stereotaxic frame
(Kopf, Tujunga, CA, USA). Viruses were mixed at a 1 : 1 ratio and then injected
unilaterally (0.5 μl) into the CA1 (A/P, 2.1 mm from bregma; M/l, 2 mm; D/V from
skull, 1.4 mm) at a rate of 0.2 μl/min with a Hamilton syringe and cannula (33
gauge). Animals were killed at 7 months of age. Quantification was performed by
ImageJ software and the 'Analyze Particles' plug-in for synaptic and mitochondrial
size, and the ImageJ colocalization plug-in for mitochondrial occupancy at the
synapse (RRID:nif-0000-30467).
Histology. For histology experiments, mice were anaesthetized and perfused
with phosphate-buffered saline (PBS), and then 4% paraformaldehyde. Brains were
then removed, postfixed in PFA (overnight, or for 2 h for Drp1 staining), and
cryoprotected in 30% sucrose. Coronal brain slices (30 or 50 μm for Drp1 levels)
were prepared using a sliding microtome (Leica SM2000R). To analyze
hippocampal volume, brain slices (40 μm thickness) were frozen in superchilled
isopentane and prepared with a Leica cryostat (Leica CM1900).
For immunofluorescence, sections were blocked for ≥ 1 h in PBS with 0.2% Triton
X-100 and 10% bovine calf serum and then incubated with primary antibodies
overnight at RT. The following primary antibodies were used: mouse anti-Drp1
(1 : 200; BD Biosciences, San Jose, CA, USA; clone 8); chicken anti-MAP2 (1 : 1500;
Abcam, Cambridge, MA, USA; Cat# ab5392 RRID:AB_2138153); mouse anti-NeuN
(1 : 1000; Millipore, Darmstadt, Germany; Cat# MAB377 RRID:AB_2298772); rabbit
anti-Tom20 (1 : 500; Santa Cruz, Dallas, TX, USA; Cat# SC-11415, RRID:
AB_2207533); mouse anti-MAP2 (1 : 1000; Millipore Cat# MAB3418 RRID:
AB_94856); rabbit anti-calbindin (1 : 20000; Swant, Marly, Switzerland; Cat# 300
RRID:AB_10000347); rabbit anti-dsRed (1 : 1000; Clontech, Mountain View, CA,
USA; Cat# 632496 RRID:AB_10015246). Sections were rinsed and incubated for 2 h
at RTwith the corresponding secondary antibodies: Alexa Fluor 488, 594, or 647 anti-
mouse, chicken, or rabbit IgG (1 : 250–1 : 500; Invitrogen, Grand Island, NY, USA).
For peroxidase staining, sections were incubated with rabbit anti-dsRed, followed by
biotinylated goat anti-rabbit IgG (1 : 300; Vector Laboratories, Burlingame, CA, USA;
BA-1000, RRID:AB_2313606), and subsequently streptavidin-conjugated horse-
radish peroxidase (1 : 300; Vectastain ABC kit, Vector Laboratories). Immunostaining
was visualized with hydrogen peroxide and 3,3′-diaminobenzidine (DAB, Sigma,
St. Louis, MO, USA).
Brain sections were imaged with a laser-scanning confocal microscope (LSM510-
Meta; Carl Zeiss, Jena, Germany) with a × 63 (1.4 NA) PlanApo oil objective, a Nikon
Ti-E inverted microscope with a × 60 (1.2 NA) PlanApo water objective, or a Keyence
inverted microscope BZ-9000 with a × 10 (0.45 NA) CFI PlanApo λ objective. Volume
was calculated with the Cavalieri principle.51 Quantification of fluorescence and area
was performed blind to genotype with MetaMorph software (version 7.7.3.0;
Molecular Devices, Sunnyvale, CA, USA; RRID:SciRes_000136). Neuronal density
was calculated by dividing the total fluorescence of NeuN in a fixed area in CA1
(a surrogate for the total number of neurons in this area) by the average NeuN
intensity per CA1 neuron. Quantification of cells with swollen mitochondria was
scored blind to genotype, based on the presence of three or more swollen
mitochondria in a cell (a subjective criteria chosen to distinguish Drp1cKO versus
control mitochondria).
Neuronal culture and live imaging. Postnatal hippocampal neuronal
cultures were prepared from P0 Drp1lox/lox mice as described4 and transfected
via electroporation (Amaxa; Lonza, Basel, Switzerland) with one or more of the
following constructs, all expressed in the pCAGGS vector downstream of the
chicken actin promoter:28 ATP-YEMK (kind gift of Dr Noji, Osaka University),24
mCherry-synaptophysin,52 BFP2-synaptophysin, VGLUT1-pHluorin-ires-mCherry-
synaptophysin,28,52 Cre recombinase,4 mCherry-Cre, mCherry, mitoGFP,53
mitoFarRed, or mitoTagBFP. mitoFarRed and mitoTagBFP were generated by
fusing TagRFP657 or TagBFP (kind gifts from Vladislav Verkhusha, Albert Einstein),
respectively, to the mitochondria-targeting sequence, cytochrome C oxidase subunit
VIII.54,55 Neurons were cultured for 8–11 days before live imaging or analysis.
Live imaging was performed in Tyrode’s medium (pH 7.4; 127 mM NaCl, 10 mM
HEPES-NaOH, 2.5 mM KCl, 2 mM MgCl2, and 2 mM CaCl2 with 30 mM glucose and/
or 10 mM pyruvate) on a Nikon Ti-E inverted microscope with an iXon EMCCD
camera (Andor Technology, Belfast, UK) and a perfusion valve control system (VC-8,
Warner Instruments, Hamden, CT, USA) controlled by MetaMorph Software. Field
stimulation (10 Hz × 60 s) was performed with an A385 current isolator and a SYS-
A310 accupulser signal generator (World Precision Instruments, Sarasota, FL, USA).
Glycolysis was inhibited with 2-DG (2.5–5 mM, Sigma-Aldrich, St. Louis, MO, USA)
and iodoacetate (1 mM, Sigma-Aldrich).
VGLUT1-pHluorin fluorescence images were obtained (490/20 ex, 535/50 em,
Chroma, Bellows Falls, VT, USA) and regions of interest were drawn over synaptic
boutons with MetaMorph software. Synaptic boutons were identified based on
colocalization with mCherry-synaptophysin and an increase in pHluorin fluorescence
after applying ammonium chloride (50 mM). For each bouton, the background-
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subtracted change in fluorescence at each time point was normalized to the
fluorescence in ammonium chloride (which estimates the total size of the synaptic
vesicle pool)29 measured at the end of each run. The baseline fluorescence intensity
was set to zero at t= 100 s before the first stimulation and t= 170 s before the
second stimulation.
For FRET experiments, sequential images were taken in the CFP (430/24 ex,
470/24 em), YFP (500/20 ex, 535/30 em), and FRET channels (430/24 ex, 535/30
em) with an ET ECFP/EYFP filter set (Chroma). Synaptic boutons were identified
based on colocalization with mCherry-synaptophysin or determined by morphology
for experiments with mitoFarRed. Synaptic boutons were classified as containing or
lacking mitochondria based on images taken immediately before and after the
imaging run. The FRET/donor ratio was calculated for each bouton as described,56
where FRET= (IFRET − ICFP × BTCFP—IYFP × BTYFP)/ICFP, such that IX is the
background-corrected fluorescence intensity measured in a given channel. BTCFP
(donor bleed through) and BTYFP (direct excitation of the acceptor) were calculated by
expressing CFP and YFP individually and determining the ratios of IFRET/ICFP and
IFRET/IYFP, respectively.
Respiration and glycolysis in MEFs. Respiratory and glycolytic rates in
four wild-type and four knockout MEF cell lines were measured with the XF Analyzer
96-well plate reader. MEFs were seeded at 20 000 cells/well 24 h before reading.
Then, they were incubated in Seahorse DMEM with 30 mM glucose 1 h before and
also during metabolic readings. Respiration and glycolysis were simultaneously
measured based on oxygen consumption rates and media acidification, respectively.
Oligomycin (1μM) was injected, followed by FCCP (1 μM) and then rotenone
(1 μM). Metabolic rates were normalized to cell numbers based on DAPI counts.
Statistical analysis. To analyze learning by MWM testing, we fit a linear
mixed effects model20 of the natural log of the distance traveled on time (trial) using
the R Project for Statistical Computing (RRID:nif-0000-10474) package lme4. To
allow for nonlinearity in the curves, we included a quadratic effect of time. We
included fixed intercepts and slopes for each of the two genotypes, each of the two
age groups, possible interactions of these effects, and random intercepts for each
mouse to account for the correlation among repeated observations.
The assumptions of a normal distribution (normality) and equal variance among
the groups (homoscedasticity) were checked by looking at the distribution of the
residuals (difference between observed and fitted values) and the fitted values from
the model. A natural logarithmic transformation of the response variable was deemed
necessary as the assumptions of normality and homoscedasticity were violated. The
estimates from the model were back transformed to the original scale.57
We used the fitted model to obtain estimates of the mean distance on the fourth
and eighth trials for each group. We used the function sim() from the arm package to
obtain 5000 simulations of the estimates and compute a 95% confidence interval (CI)
around each estimate as the 2.5th and 97.5th quantiles of these draws. We calculated
P-values for differences between groups by inverting the simulated CIs around the
differences.58 These P-values were corrected for multiple comparisons using the
method of Holm.
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